True Private Wealth Advisors Biogen Inc. Transaction History

True Private Wealth Advisors

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$242.95 - $284.63 $32,798 - $38,425	-135 Closed	0 $0
Q3 2020 Oct 09, 2020	BUY	$264.77 - $305.71 $9,266 - $10,699	35 Added 35.0%	135 $38,000
Q1 2020 Apr 20, 2020	SELL	$268.85 - $341.04 $308,370 - $391,172	-1,147 Reduced 91.98%	100 $31,000
Q4 2019 Jan 27, 2020	BUY	$220.06 - $304.07 $22,006 - $30,407	100 Added 8.72%	1,247 $370,000
Q2 2019 Aug 01, 2019	BUY	$219.29 - $241.72 $4,824 - $5,317	22 Added 1.96%	1,147 $268,000
Q1 2019 Apr 25, 2019	SELL	$216.71 - $338.96 $6,284 - $9,829	-29 Reduced 2.51%	1,125 $265,000
Q3 2018 Oct 18, 2018	BUY	$293.51 - $383.83 $880 - $1,151	3 Added 0.26%	1,154 $0
Q2 2018 Jul 13, 2018	SELL	$257.52 - $306.91 $6,953 - $8,286	-27 Reduced 2.29%	1,151 $334,000
Q4 2017 Jan 19, 2018	BUY	$307.64 - $344.58 $13,228 - $14,816	43 Added 3.79%	1,178 $375,000
Q2 2017 Aug 07, 2017	BUY	N/A	1,135	1,135 $307,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of True Private Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on True Private Wealth Advisors with notifications on news.